Embolic strokes of undetermined source in the athens stroke registry: A descriptive analysis

Stroke

Volumn 46, Issue 1, 2015, Pages 176-181

  Ntaios, George ^a   Papavasileiou, Vasileios ^a   Milionis, Haralambos ^b   Makaritsis, Konstantinos ^a   Manios, Efstathios ^c   Spengos, Konstantinos ^d   Michel, Patrik ^e   Vemmos, Konstantinos ^c  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c ALEXANDRA HOSPITAL   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

covert atrial fibrillation; cryptogenic; embolic stroke of undetermined cause; embolism; ESUS

Indexed keywords

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREVALENCE; PROSPECTIVE STUDY; RECURRENT DISEASE; REGISTER; RISK FACTOR; ATRIAL FIBRILLATION; COHORT ANALYSIS; COMPLICATION; ELECTROCARDIOGRAPHY; GREECE; INTRACRANIAL EMBOLISM; MIDDLE AGED; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN INFARCTION; COHORT STUDIES; DYSLIPIDEMIAS; ELECTROCARDIOGRAPHY; FEMALE; GREECE; HUMANS; HYPERTENSION; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STROKE;

EID: 84920122944     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007240     Document Type: Article

References (20)

1. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al; EMBRACE Investigators and Coordinators. Atrial fbrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467-2477.
2. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fbrillation. N Engl J Med. 2014;370:2478-2486.
3. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429-438.
4. Vemmos KN, Takis CE, Georgilis K, Zakopoulos NA, Lekakis JP, Papamichael CM, et al. The Athens stroke registry: results of a fve-year hospital-based study. Cerebrovasc Dis. 2000;10:133-141.
5. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
6. Gray LJ, Ali M, Lyden PD, Bath PM; Virtual International Stroke Trials Archive Collaboration. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis. 2009;18:466-468.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
8. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al; Expert Committee on the Diagnosis and Classifcation of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-3167.
9. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) fnal report. Circulation. 2002;106:3143-3421.
10. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al; ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933-989.
11. Advisory Council for the National Institute of Neurological and Communicative Disorders and Stroke NIoH. A classifcation and outline of cerebrovascular diseases. II. Stroke. 1975;6:564-616.
12. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541-553.
13. Ntaios G, Vemmou A, Koroboki E, Savvari P, Makaritsis K, Saliaris M, et al. The type of atrial fbrillation is associated with long-term outcome in patients with acute ischemic stroke. Int J Cardiol. 2013;167:1519-1523.
14. Diener HC, Connolly S, Easton J, Smith J, Duffy C, Bruckmann M. Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS). Cerebrovasc Dis. 2014; 37(suppl 1):261.
15. The NAVIGATE ESUS trial. Population Health Research Institute. http://www.phri.ca/research/stroke-cognition/navigate-esus-111/. Accessed October 12, 2014.
16. Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78:1916-1922.
17. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, et al. Selecting patients with atrial fbrillation for anticoagula-tion: stroke risk stratifcation in patients taking aspirin. Circulation. 2004;110:2287-2292.
18. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classifcation schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870.
19. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refning clinical risk stratifcation for predicting stroke and thromboembolism in atrial fbrillation using a novel risk factor-based approach: the euro heart survey on atrial fbrillation. Chest. 2010;137:263-272.
20. Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, et al. CHADS2, CHA2S2DS2-VASc, and long-term stroke outcome in patients without atrial fbrillation. Neurology. 2013;80:1009-1017.